Oncolytics Biotech: Falls after wider loss, stock and warrants offering

Oncolytics Biotech

14/08/2019 11:56

** Biotech's U.S.-listed shares  ONCY.O  down 13.3% at $0.78
premarket - second biggest pct loser among U.S. stocks
    ** Posts wider-than-expected loss, according to three
analysts polled by Refinitiv IBES  urn:newsml:reuters.com:*:nACSW1SSla
    ** Also announces stocks and warrants offering; ONCY has
market cap of $18.3 mln  urn:newsml:reuters.com:*:nACSbWHFLa
    ** Co intends to use net proceeds of offering for research
and development activities
    ** With more than 24.7k shares traded by 6:50 a.m. ET, ONCY
among the top 10 most heavily traded U.S. stocks premarket
    ** ONCY down 50.3% YTD

 (Reporting by Arjun Panchadar in Bengaluru)